OBJECTIVES Chronic kidney disease (CKD) is characteristically accompanied by changes in arterial stiffness, and related to increased occurrence of cardiovascular disease. The links between arterial stiffness and circulating vascular growth factors are not well described.
METHODS Patients with CKD stages 2-5 who were not on dialysis (n¼156, male/female¼91/65; age¼61.4AE10.9 years) were included. Brachial-ankle pulse wave velocity (baPWV) was used as a measure of arterial stiffness. Blood samples to measure hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1) were obtained.
RESULTS Serum levels of HGF and VEGF were correlated with estimated glomerular filtration rate (eGFR) in patients with chronic renal diseases. Compared with patients with early CKD (stages 2-3), patients with late CKD (stages 4-5) had elevated serum levels of HGF (P ¼ 0.026) and VEGF (P ¼ 0.034), while IGF-1 was slightly increased in patients with late CKD (P ¼ 0.057). In univariate analysis, PWV positively correlated with HGF (r ¼ 0.27, P ¼ 0.016), VEGF (r ¼ 0.30, P ¼ 0.035), and negatively with eGFR (r ¼ -0.29, P ¼ 0.028). In a multivariate analysis only HGF was independent determinant of higher PWV.
CONCLUSIONS Circulating levels of HGF may be a new marker of cardiovascular damage in patients with CKD.
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High central venous pressure is associated with acute kidney injury and mortality in patients underwent cardiopulmonary bypass surgery Yanli Yang, Enming Qing, Jun Ma Beijin Anzhen Hospital, Capital Medical University OBJECTIVES The pathophysiology of AKI after cardiovascular surgery is multifactorial. The relative importance of high central venous pressure (CVP) has not been addressed previously.We sought to investigate the relationship between high CVP, AKI, and mortality in patients undergoing cardiac surgery with cardiopulmonary bypass.
METHODS All patients aged 18 years or older who underwent cardiac surgery with CPB between July 1, 2013, and May 31, 2014, were prospectively reviewed. Patients were excluded when renal artery were involved before and during surgery. Patients were dichotomized into 1) High CVP group: CVP value was higher than 10 mmHg, and 2) Low CVP group: CVP value was lower than 10 mmHg. CVP measurement was referred to the fourth intercostal level at the end of surgery. All patients were followed by telephone. The primary outcome was AKI and mortality. AKI was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria.
RESULTS A total of 1941 patients were included in this prospectively observed study between July 1, 2013, and May 31, 2014 in AnZhen Hospital. Mean age was 51.95AE13.65 years, and 46.26% patients were male. Valve surgery (1232, 63.47%) was the major surgery type. 30-day mortality was 1.86% overall. Of all patients, 433(22.31%) developed AKI. In high CVP group, the KDIGO stage1 (34.33 %), stage 2 (5.74%), and stage3 (0.31%) were respectively higher than that in low CVP group with stage 1 (5.53 %), stage 2 (0.96%), and stage 3 (1.05%). In a median follow-up time of 9.2 months, 89(4.59%) patients died. In multivariate analysis, CVP remained the independent predictor of survival (hazard ratio:1.2 per mmHg increase, 95% confidence interval: 1.11-1.29, P <0.0001).
CONCLUSIONS High level of CVP is associated with the development of AKI, which suggests a role of venous congestion in developing. High CVP was independently related to all-cause mortality in patients undergoing cardiovascular surgery with cardiopulmonary bypass. Further studies will need to assess whether or not CVP at the end of surgery could be used to guide intervention and improve outcomes.
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Assessment of Left Ventricular Dissipative Energy Loss by Vector Flow Mapping in End Stage Renal Disease Patients
Yue Zhong, Li Rao Department of cardiology, West China Hospital of Sichuan University, Chengdu, China OBJECTIVES To assess left ventricular dissipative energy loss (EL) by vector flow mapping in subjects with end-stage renal disease (ESRD), and to evaluate the connection between blood flow efficiency and asymptomatic changes in cardiac function.
METHODS ESRD patients with preserved left ventricular ejection fraction that consisted of group on peritoneal dialysis (PD group), group on hemodialysis (HD group) and group on preparation for dialysis session (PRE group) were examined by echocardiography as well as normal subjects. Vector flow mapping analysis was then performed from the apical 4-chamber view to calculate the EL value during diastole and systole in the left ventricle (LV).
RESULTS
Conventional transthoracic echocardiography and left ventricular EL calculation were successfully performed in 63 cases and 50 controls. Mean diastolic EL were 90.18AE61.11 versus 25.14AE11.57 mW/m (P <0.001) and mean systolic EL 26.85AE10.66 versus 13.30AE5.26mW/m (P <0.001) in cases and controls, respectively. Significant difference between PD group and PRE group in diastolic EL was found (66.98AE40.59 versus 114.22AE70.52 mW/m, P ¼0.035). The diastolic EL had a significant correlation with E/e' ratio (r ¼0.746, P <0.001), and the systolic EL was positively related with the diastolic EL (r ¼0.617, P <0.001).
CONCLUSIONS Impaired blood flow efficiency was detected in ESRD patients using dissipative EL derived from vector flow mapping. The EL value could be used to evaluate therapeutic effects of dialysis upon cardiac function in ESRD patients.
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Serum cystatin C is associated with reverse-dipper pattern of blood pressure in hypertensive patients (BP) have been reported before. Recently, reverse-dipper pattern of BP, one of short-term BP variability, was gradually recognized as an emerging risk factor for cardiovascular, metabolic and renal diseases. However, the association of serum cystatin C (s-CC), a marker of early kidney injury, with reverse-dipper BP pattern remains unknown.
METHODS A total of 718 hypertensive patients were eventually included and evaluated with 24 hours ambulatory BP monitoring (ABPM).Peripheral venous blood samples were collected to evaluate the s-CC levels by sandwich enzyme-linked immunoassay. According to the range of the nocturnal decline of systolic BP (SBP), circadian BP variations can be classified dippers (10%-20% SBP fall), nondippers (0%-10% SBP fall), and reverse-dippers (<0% SBP fall).-Exclusion criteria were <18 or >90 years old, under antihypertensive treatment, night workers, acute stroke or myocardial infarction within the past 6 months, sleep apnea syndrome, secondary hypertension, could not tolerate the ABPM, and other chronic diseases. The distribution of hypertensive patients with different levels of s-CC among each circadian BP pattern group was analyzed using analysis of variance. Multinomial logistic regression analysis was applied to explore the relationship between the relevant variables and ABPM results.
RESULTS S-CC level in reverse dipper group (1.18AE0.52) was increased significantly when compared with dipper group (1.05AE0.36) (P¼0.021).In addition, after multinomial logistic regression analysis, s-CC (OR 1.723; 95% CI 1.060-2.800; P¼0.028) and diabetes (OR 2.033; 95% CI 1.249-3.308; P¼0.004) were significantly different between reverse dipper group and dipper group. On the other hand, the decline rate of nocturnal SBP was negatively correlated with s-CC level (r¼-0.117; p¼0.002).
CONCLUSIONS Our study suggested that s-CC was associated with reverse-dipper pattern of BP examined with 24h ABPM. The hypertensive patients with higher s-CC level were more frequently found to be reverse dippers. Moreover, the lower nocturnal decline rate of SBP might increase the risk of s-CC and early renal injury in hypertensive patients probably.
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The combined detection of serum uric acid and ankle brachial index to screen for chronic kidney disease Miaomiao Zhao, Jie Zhang, Jue Li Heart, Lung and Blood Vessel Center, Tongji University School of Medicine, Shanghai, China OBJECTIVES It has been identified that elevated serum uric acid (SUA) level is associated with increased risk of chronic kidney disease (CKD), and abnormally higher or lower ankle brachial index (ABI) value has been reported to be independent risk factors of CKD. However, to our knowledge, no publication has estimated the combined detection of SUA and ABI to screen for CKD. The purpose of this study was to evaluate the association of SUA and ABI with CKD, and investigate the combined detection of SUA and ABI to screen for CKD in Chinese hospital inpatients.
METHODS A total of 3732 inpatients aged over 35 years and at high risk of atherosclerosis were enrolled from eight university-affiliated hospitals located in Beijing and Shanghai. Complete baseline data were obtained from 3557 of them. Logistic regression analysis was utilized to assess the association of SUA and ABI with CKD and ROC curves were performed to evaluate the combined detection of SUA and ABI to screen for CKD compared to SUA alone.
RESULTS After multivariable adjustment for age, gender, and other confounders, patients with the second, third and fourth quartile of SUA had the ORs of 2.274 (95% CI, 1.696-3.049), 3.770 (95% CI, 2.833-5.015) and 8.532(95% CI, 6.435-11.312) when the lowest quartile selected as reference. Compared to the individuals with an ABI ! 1.00, the ORs for patients with ABI: 0.91-0.99, 0.41-0.90, 0.40 were 1.499 (95% CI, 0.932-2.411), 1.996 (95% CI, 1.206-3.306) and 2.636 (95% CI, 1.641-4.236) after multivariable adjustment. AUCs of ROC curves for combined SUA and ABI to screen for CKD were 0.731, 0.734, and 0.755 in all population, males and females. And the corresponding AUCs for SUA alone were 0.702, 0.698 and 0.741,(all p <0.01).
CONCLUSIONS A high SUA level was independently associated with a high risk of CKD. There was an inverse association between ABI and CKD. The combination of a detection of SUA and ABI evaluation can constitute a more efficient means to screen for CKD among the people at heightened risk in Chinese.
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Role of Akt/mTOR signal pathway in iodine contrast agent-induced apoptosis in diabetic rat kidneys Zhanquan Jiao, Guangping Li Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University OBJECTIVES The risk of contrast-induced acute kidney injury (CIAKI) is significantly increased in patients with diabetes mellitus. This study aimed to investigate molecular mechanisms of contrast media induced apoptosis in diabetic rat kidneys, especially the involvement of Akt/mTOR signal pathway.
METHODS Diabetic Sprague-Dawley rats were induced by intraperitoneal injection of streptozotocin. Ten weeks later the normal and diabetic rats were administered high-osmolar contrast media (HOCM; meglumine diatrizoate) or normal saline (10 ml/kg) injection for two consecutive days. At 24h after the operation, the rats were sacrificed, the blood samples were collected for examining serum creatinine and the kidneys were collected for determining the expression of caspase-3 by immunohistochemistry and the expression of Bcl-2, Bax, upstream signal molecule p-Akt and p-mTOR by western blotting.
RESULTS
The serum creatinine was significantly increased in diabetes þ contrast media group (DC group) after operation compared with in the diabetic group (D group) (103.89AE9.01 mmol/L vs 71.52AE7.03 mmol/L, p<0.05). While creatinine clearance rate (Ccr) was significantly decreased in DC group after operation (1.49AE0.33 ml/min vs 2.60AE0.54 ml/min, p<0.05). Especially in the diabetic kidney, the expression of caspase-3 was also significantly increased after intravenous injection of HOCM compared with normal saline. And the expression of anti-apoptosis Bcl-2 protein was significantly decreased in DC group after the induction of DTZ, while the expression of promoting apoptosis protein Bax was significantly increased (0.90AE0.13 vs 1.50AE0.16; 0.92AE0.04 vs 0.51AE0.05, both p<0.05). The activity of upstream signal molecule p-Akt and p-mTOR was significantly decreased (0.46AE0.08 vs 0.68AE0.07; 0.19AE0.04 vs 0.50AE0.07, both p<0.05).
CONCLUSIONS The ionic high osmolality CM induce severe renal cells apoptosis in diabetic rats through activating the caspase-3 apoptotic pathway, which might be mediated by upstream Akt/mTOR (inhibiting p-Akt and p-mTOR expression) signal pathway.
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Lovastatin attenuates cyclosporine inhibition of ROMK1 channels by liberating PI(4,5)P2 from microvilli OBJECTIVES Cyclosporine A(CsA), an immunosuppressant drug which can causes hyperkalemia. However, the machanism remains unclear. As a member of Kir channel superfamily, ROMK1 plays an important role in potassium secretion of distal nephron. We have validated that CsA can elevates intracellular cholesterol and inhibits ROMK1 activity in renal collecting duct epithelial cells. Interestingly, it has been shown that cholesterol inhibits Kir channels including ROMK1 channel. Therefore, investigating how cholesterol regulates ROMK1 becomes emphasis.
METHODS We used cultured mouse cortical collecting duct principal cells (mpkCCDc 14 line) combined with a variety of experimental methods, especially with patch-clamp(cell-attached and inside-out), confocal and scanning ion conductance microscopy (SICM) techniques to illuminate the pathway of ROMK1 regulation by cholesteroldependent distribution of PI(4,5)P 2 .
RESULTS Patch-clamp data demonstrated that a small conductance Kþ (ROMK1) channel in mpkCCDc 14 cells was inhibited by cholesterol and activated by extraction of cholesterol with methyl-bcyclodextrin (MbCD), implying a possible association between cholesterol and ROMK1. However, confocal microscopy data showed that ROMK1 was not in the microvilli where cholesterol-rich lipid rafts are located, but rather in planar regions of the apical membrane of mpkCCDc 14 cells, and that phosphatidylinositol-4,5bisphosphate (PI(4,5)P 2 ), a well-known activator of ROMK channels,
